Vote On Orange And Purple Book Bills Should Mark Beginning Of A Series Of Legislative Actions To Deliver On Rising Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement encouraging members of the U.S. House of Representatives to pass the first two bills on drug pricing scheduled to […]
Greater List Price Transparency Will Help Hold Big Pharma Accountable Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement following an announcement by the U.S. Department of Health and Human Services (HHS) that drug manufacturers will be required to disclose their pricing information in direct-to-consumer (DTC) advertising beginning in July: […]
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement commending the Senate Committee on the Judiciary for holding a hearing on the role of patent abuse in increasing prescription drug prices. Senators, from both sides of the aisle, grilled a witness representing large pharmaceutical manufacturers, expressed their commitment to action […]
Encourages Judiciary Committee To Hold Drug Makers Accountable, Seek Solutions To Spur Competition Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a Tuesday U.S. Senate Committee on the Judiciary hearing on the topic of prescription drug patents. “Big Pharma has gamed the patent system to crowd out […]
Nonpartisan Analysis Projects HHS Proposal A $187 Billion Budget-Buster That Would Hike Premiums On Seniors Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement in response to the Congressional Budget Office’s (CBO) release of an analysis on the U.S. Department of Health and Human Services’ (HHS) proposed Rebate Rule: “The […]
Praises Lawmakers For Commitment To Delivering Relief For Patients Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement applauding the U.S. House Committee on the Judiciary for voting to advance the bipartisan CREATES Act at a legislative markup. The measure targets certain anti-competitive tactics employed by Big Pharma to maintain […]
Encourages House Judiciary Committee To Advance Bipartisan CREATES Act Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a pair of hearings on Capitol Hill Tuesday. “These hearings and the legislative activity in Washington on the crisis of prescription drug prices are a welcome indication policymakers, on both […]
Filings Show Drug Makers Spent Nearly $10 Million on Lobbying in Q1 2019 – Up 30 Percent from Q1 2018 Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement in response to new filings indicating pharmaceutical companies spent a near-record $9.91 million in lobbying during the first quarter of 2019 […]
Bipartisan Bill Would Take Meaningful Steps To Crack Down On Big Pharma’s Evergreening, Patent Abuse Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement on the introduction of the Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act by Senators Bill Cassidy (R-LA) and Dick Durbin (D-IL). “Big Pharma’s […]
Bloomberg Analysis Finds Medicare Spending On 22 Drugs Jumped More Than 500 Percent In Five Years Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on a new Bloomberg Government analysis that reveals the cost for 22 drugs increased more than 500 percent per dose from 2013 through 2017. “Big […]